Gene Expression Market Report and Forecast 2025-2034
Description
The global gene expression market attained a value of USD 13.30 Billion in 2024. The market is further expected to grow in the forecast period of 2025-2034 at a CAGR of 10.40%, to reach USD 35.77 Billion by 2034.
The gene expression market growth is driven by the rapid advancements in the field of genomics. In pharmaceutical companies, gene expression analysis is increasingly employed for drug discovery and development to accommodate the clinical needs of the growing patient population. On the other hand, biotechnology companies are actively investing in the market to develop novel therapies. Additionally, the rising prevalence of chronic diseases such as cancer and the substantial funding for genomic research is expected to accelerate the market growth in the forecast period.
Global Gene Expression Market Trends and Developments
Growing preference for personalized medicine, rising demand for precision oncology, expansion of RNA sequencing applications, and increasing use of gene expression research in infectious disease research comprise some of the key trends and developments in the market.
Growing Preference for Personalized Medicine
Gene expression analysis facilitates understanding of disease mechanisms and helps identify targeted therapies. The growing focus on personalized medicine, in which a specific treatment plan is designed based on the patient’s genetic makeup, is elevating the gene expression market value.
Rising Demand for Precision Oncology
Gene expression analysis is increasingly used in oncology to identify molecular signatures of tumors. Thus, the advancement in genomics is fuelling a shift towards more precise and personalized cancer care.
Expansion of RNA Sequencing Applications
RNA sequencing (RNA-seq) is expanding beyond basic research into clinical applications, including disease diagnosis, treatment monitoring, and understanding of the immune response.
Increasing Use of Gene Expression in Infectious Disease Research
Gene expression profiling finds its application in infectious disease research such as the immune response to infections and identifying potential therapeutic targets for emerging pathogens. With the rising prevalence of infectious diseases and the growing demand for effective therapeutics, the market is expected to witness a surge.
August 2023
Almac Diagnostic Services (a member of the contract development and manufacturing organization Almac Group) expanded its NGS portfolio of DNA sequencing service offerings by investing in Illumina NovaSeq X Plus in its Ireland facility.
July 2023
Neoleukin Therapeutics, Inc., entered into a merger agreement with Neurogene Inc., a biotechnology company focused on the development of genetic medicines for rare neurological diseases. The merger is expected to strengthen the genetic drug pipeline of Neurogene Inc. and develop medications for rare diseases such as Rett Syndrome.
March 2023
Illumina Inc. launched its first whole genome sequencing (WGS) assay called ‘Illumina Complete Long Read Prep Human’ that has been compatible with multiple sequencing systems. The product offers both long and short-read sequencing on the NovaSeq platform, along with simplified workflows and reduced DNA input requirements. Early customer data demonstrates high accuracy and flexibility, with the promotional price at USD 1,350 per whole genome.
March 2023
Chroma Medicine, Inc., secured USD 135 million in series B financing led by Google Ventures. The firm plans to use the investment to expand its precision genomic medicines portfolio and develop its epigenetic editing technology.
Global Gene Expression Market Demand
The market demand is propelled by the application of gene expression technologies across various domains from basic research to diagnostics and drug discovery. Heightened patient awareness and increased accessibility to healthcare services further bolster the market demand. The rising prevalence of genetic disorders has increased the focus on gene expression studies to identify potential therapeutic targets. With the data suggesting that 72% of rare diseases have a genetic origin, the gene expression market size is projected to expand in the forecast period.
Technological advancements such as the integration of artificial intelligence (AI) and machine learning in gene expression analysis are anticipated to contribute to market growth. Such innovations will simplify complex data and assist in predicting treatment outcomes, facilitating the utilization of gene expression profiles in clinical decision-making.
Global Gene Expression Market Segmentation
“Global Gene Expression Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Breakup by Products and Services
The key market players are contributing to the gene expression market growth through strategic mergers and acquisitions initiatives, novel product launches, and continuous research and development efforts aimed at providing improved patient solutions.
Other key players in the market include Revvity Inc., Agilent Technologies Inc., Oxford Nanopore Technologies Inc., PacBio, QIAGEN, Bio-Rad Laboratories Inc., Danaher Life Sciences, and Takara Bio Inc.
Global Gene Expression Market Analysis by Region
In North America, the market is witnessing significant growth which can be attributed to robust research and development efforts aimed at expanding the genomics field. Major funding from the public and private sectors also supports the ongoing gene expression studies. In addition, the presence of a well-established healthcare system and growing demand for targeted therapies is expected to boost the gene expression market size in the forecast period.
Asia Pacific is projected to experience rapid growth in the coming years supported by the rising disposable income and improvement of healthcare facilities. Moreover, the regional market offers lucrative growth opportunities for the key market players due to various factors such as the huge population base, rising prevalence of chronic diseases, and increased expenditure on healthcare services and products.
*Please Note:* The report will take 5 business days to complete, after order confirmation.
The gene expression market growth is driven by the rapid advancements in the field of genomics. In pharmaceutical companies, gene expression analysis is increasingly employed for drug discovery and development to accommodate the clinical needs of the growing patient population. On the other hand, biotechnology companies are actively investing in the market to develop novel therapies. Additionally, the rising prevalence of chronic diseases such as cancer and the substantial funding for genomic research is expected to accelerate the market growth in the forecast period.
Global Gene Expression Market Trends and Developments
Growing preference for personalized medicine, rising demand for precision oncology, expansion of RNA sequencing applications, and increasing use of gene expression research in infectious disease research comprise some of the key trends and developments in the market.
Growing Preference for Personalized Medicine
Gene expression analysis facilitates understanding of disease mechanisms and helps identify targeted therapies. The growing focus on personalized medicine, in which a specific treatment plan is designed based on the patient’s genetic makeup, is elevating the gene expression market value.
Rising Demand for Precision Oncology
Gene expression analysis is increasingly used in oncology to identify molecular signatures of tumors. Thus, the advancement in genomics is fuelling a shift towards more precise and personalized cancer care.
Expansion of RNA Sequencing Applications
RNA sequencing (RNA-seq) is expanding beyond basic research into clinical applications, including disease diagnosis, treatment monitoring, and understanding of the immune response.
Increasing Use of Gene Expression in Infectious Disease Research
Gene expression profiling finds its application in infectious disease research such as the immune response to infections and identifying potential therapeutic targets for emerging pathogens. With the rising prevalence of infectious diseases and the growing demand for effective therapeutics, the market is expected to witness a surge.
August 2023
Almac Diagnostic Services (a member of the contract development and manufacturing organization Almac Group) expanded its NGS portfolio of DNA sequencing service offerings by investing in Illumina NovaSeq X Plus in its Ireland facility.
July 2023
Neoleukin Therapeutics, Inc., entered into a merger agreement with Neurogene Inc., a biotechnology company focused on the development of genetic medicines for rare neurological diseases. The merger is expected to strengthen the genetic drug pipeline of Neurogene Inc. and develop medications for rare diseases such as Rett Syndrome.
March 2023
Illumina Inc. launched its first whole genome sequencing (WGS) assay called ‘Illumina Complete Long Read Prep Human’ that has been compatible with multiple sequencing systems. The product offers both long and short-read sequencing on the NovaSeq platform, along with simplified workflows and reduced DNA input requirements. Early customer data demonstrates high accuracy and flexibility, with the promotional price at USD 1,350 per whole genome.
March 2023
Chroma Medicine, Inc., secured USD 135 million in series B financing led by Google Ventures. The firm plans to use the investment to expand its precision genomic medicines portfolio and develop its epigenetic editing technology.
Global Gene Expression Market Demand
The market demand is propelled by the application of gene expression technologies across various domains from basic research to diagnostics and drug discovery. Heightened patient awareness and increased accessibility to healthcare services further bolster the market demand. The rising prevalence of genetic disorders has increased the focus on gene expression studies to identify potential therapeutic targets. With the data suggesting that 72% of rare diseases have a genetic origin, the gene expression market size is projected to expand in the forecast period.
Technological advancements such as the integration of artificial intelligence (AI) and machine learning in gene expression analysis are anticipated to contribute to market growth. Such innovations will simplify complex data and assist in predicting treatment outcomes, facilitating the utilization of gene expression profiles in clinical decision-making.
Global Gene Expression Market Segmentation
“Global Gene Expression Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Breakup by Products and Services
- Consumables
- Instruments
- Services
- Polymerase Chain Reaction
- Next Generation Sequencing
- DNA Microarray
- Others
- Disease Diagnosis
- Drug Discovery
- Drug Development
- Others
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institute
- Diagnostic and Clinical Laboratories
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The key market players are contributing to the gene expression market growth through strategic mergers and acquisitions initiatives, novel product launches, and continuous research and development efforts aimed at providing improved patient solutions.
Other key players in the market include Revvity Inc., Agilent Technologies Inc., Oxford Nanopore Technologies Inc., PacBio, QIAGEN, Bio-Rad Laboratories Inc., Danaher Life Sciences, and Takara Bio Inc.
Global Gene Expression Market Analysis by Region
In North America, the market is witnessing significant growth which can be attributed to robust research and development efforts aimed at expanding the genomics field. Major funding from the public and private sectors also supports the ongoing gene expression studies. In addition, the presence of a well-established healthcare system and growing demand for targeted therapies is expected to boost the gene expression market size in the forecast period.
Asia Pacific is projected to experience rapid growth in the coming years supported by the rising disposable income and improvement of healthcare facilities. Moreover, the regional market offers lucrative growth opportunities for the key market players due to various factors such as the huge population base, rising prevalence of chronic diseases, and increased expenditure on healthcare services and products.
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Gene Expression Market Overview
- 3.1 Global Gene Expression Market Historical Value (2018-2024)
- 3.2 Global Gene Expression Market Forecast Value (2025-2034)
- 4 Global Gene Expression Market Landscape*
- 4.1 Global Gene Expression: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Gene Expression: Product Landscape
- 4.2.1 Analysis by Products and Services
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Application
- 5 Global Gene Expression Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Gene Expression Market Segmentation (218-2034)
- 6.1 Global Gene Expression Market (2018-2034) by Products and Services
- 6.1.1 Market Overview
- 6.1.2 Consumables
- 6.1.3 Instruments
- 6.1.4 Services
- 6.2 Global Gene Expression Market (2018-2034) by Technology
- 6.2.1 Market Overview
- 6.2.2 Polymerase Chain Reaction
- 6.2.3 Next Generation Sequencing
- 6.2.4 DNA Microarray
- 6.2.5 Others
- 6.3 Global Gene Expression Market (2018-2034) by Application
- 6.3.1 Market Overview
- 6.3.2 Disease Diagnosis
- 6.3.3 Drug Discovery
- 6.3.4 Drug Development
- 6.3.5 Others
- 6.4 Global Gene Expression Market (2018-2034) by End User
- 6.4.1 Market Overview
- 6.4.2 Pharmaceutical and Biotechnology Companies
- 6.4.3 Academic and Research Institute
- 6.4.4 Diagnostic and Clinical Laboratories
- 6.4.5 Others
- 6.5 Global Gene Expression Market (2018-2034) by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Gene Expression Market (218-2034)
- 7.1 North America Gene Expression Market (2018-2034) by Products and Services
- 7.1.1 Market Overview
- 7.1.2 Consumables
- 7.1.3 Instrument
- 7.1.4 Services
- 7.2 North America Gene Expression Market (2018-2034) by Application
- 7.2.1 Market Overview
- 7.2.2 Disease Diagnosis
- 7.2.3 Drug Discovery
- 7.2.4 Drug Development
- 7.2.5 Others
- 7.3 North America Gene Expression Market (2018-2034) by Country
- 7.3.1 United States of America
- 7.3.2 Canada
- 8 Europe Gene Expression Market (218-2034)
- 8.1 Europe Gene Expression Market (2018-2034) by Products and Services
- 8.1.1 Market Overview
- 8.1.2 Consumables
- 8.1.3 Instrument
- 8.1.4 Services
- 8.2 Europe Gene Expression Market (2018-2034) by Application
- 8.2.1 Market Overview
- 8.2.2 Disease Diagnosis
- 8.2.3 Drug Discovery
- 8.2.4 Drug Development
- 8.2.5 Others
- 8.3 Europe Gene Expression Market (2018-2034) by Country
- 8.3.1 United Kingdom
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Others
- 9 Asia Pacific Gene Expression Market (218-2034)
- 9.1 Asia Pacific Gene Expression Market (2018-2034) by Products and Services
- 9.1.1 Market Overview
- 9.1.2 Consumables
- 9.1.3 Instrument
- 9.1.4 Services
- 9.2 Asia Pacific Gene Expression Market (2018-2034) by Application
- 9.2.1 Market Overview
- 9.2.2 Disease Diagnosis
- 9.2.3 Drug Discovery
- 9.2.4 Drug Development
- 9.2.5 Others
- 9.3 Asia Pacific Gene Expression Market (2018-2034) by Country
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 ASEAN
- 9.3.5 Australia
- 9.3.6 Others
- 10 Latin America Gene Expression Market (218-2034)
- 10.1 Latin America Gene Expression Market (2018-2034) by Products and Services
- 10.1.1 Market Overview
- 10.1.2 Consumables
- 10.1.3 Instrument
- 10.1.4 Services
- 10.2 Latin America Gene Expression Market (2018-2034) by Application
- 10.2.1 Market Overview
- 10.2.2 Disease Diagnosis
- 10.2.3 Drug Discovery
- 10.2.4 Drug Development
- 10.2.5 Others
- 10.3 Latin America Gene Expression Market (2018-2034) by Country
- 10.3.1 Brazil
- 10.3.2 Argentina
- 10.3.3 Mexico
- 10.3.4 Others
- 11 Middle East and Africa Gene Expression Market (218-2034)
- 11.1 Middle East and Africa Gene Expression Market (2018-2034) by Products and Services
- 11.1.1 Market Overview
- 11.1.2 Consumables
- 11.1.3 Instrument
- 11.1.4 Services
- 11.2 Middle East and Africa Gene Expression Market (2018-2034) by Application
- 11.2.1 Market Overview
- 11.2.2 Disease Diagnosis
- 11.2.3 Drug Discovery
- 11.2.4 Drug Development
- 11.2.5 Others
- 11.3 Middle East and Africa Gene Expression Market (2018-2034) by Country
- 11.3.1 Saudi Arabia
- 11.3.2 United Arab Emirates
- 11.3.3 Nigeria
- 11.3.4 South Africa
- 11.3.5 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Illumina Inc.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Thermo Fisher Scientific
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Promega Corporation
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Revvity Inc.
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Agilent Technologies Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Oxford Nanopore Technologies Inc.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 F. Hoffmann La Roche Ltd.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 PacBio
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 QIAGEN
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Bio-Rad Laboratories Inc.
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Danaher Life Sciences
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Takara Bio Inc.
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
